Navigation Links
Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products

NOXO balms, when applied topically, under the nostrils help deliver scent molecules into the nose to the olfactory bulb, where the chemical and neurotransmitter messengers are dispensed into the limbic system of the brain. From there, they are forwarded to areas of the central nervous system that mediate emotional, hormonal, metabolic, and other physiological responses throughout the body.

Wynnewood, PA (PRWEB) December 18, 2009 -- Adoodle, Inc, (OTC Pink Sheets: ADDE) announced today. the company’s new Advisory Board and that it is ready to launch its new line of NOXO Behavioral Modification Products.

Advisory Board
Dr. Warren H. Chaney is the Chief Executive Officer for Mind Technologies and the developer and creator of Mind Tech’s Mind Dynamic™ technologies. He has written fifteen books, seventy-four journal and magazine articles, and entries for Colliers Encyclopedia. He has also written twelve screenplays, fourteen theatrical dramas, many episodic television and theatrical productions and countless independent research studies. He has produced nine feature films and has directed eight in addition to producing and directing numerous television productions. His film and television work has won numerous awards including those for best writer and director. Dr. Chaney is recognized as one of the nation’s leaders in the area of ABS (Audio Brain Technology).

Myron Yanoff, M.D., currently is Professor and Chairman of the Department of Ophthalmology at Drexel University College of Medicine in Philadelphia PA, USA. Formerly, he was Chairman of the Department of Ophthalmology of the University of Pennsylvania and Director of the Scheie Eye Institute, both in Philadelphia PA, USA. He has been the recipient of one of the highest honors in American science the Senior Distinguished U.S. Scientist Award (Humboldt-Award). In 1998, Ophthalmology Times named Dr. Yanoff one of the 100 Best Ophthalmologists in America. Dr. Yanoff is internationally known as a scholar, teacher, clinical innovator, and academic leader.

Michael J. Stern is President of Stern Consulting LLC a company dedicated to assisting emerging growth companies. He and his team help find value added partners and make connections to expedite the growth process. Stern Consulting also makes key introductions to help with marketing the product or technology to get it into the mainstream on a faster track. Mr. Stern is also one of the top authorities on early Disney and Beatles memorabilia. He has written seven books on the subjects. Mr. Stern also serves as an industry arbitrator for Finra.

Richard Ames retired as a stockbroker after 45 years in the financial industry and has experience in growing small companies being aware of what is needed to help them succeed. Rich has served on the board of small publicly traded medical companies. As an advisory board member, he will be aiding Adoodle expand its stockholder base because of the numerous relationships he has developed over 45 years in the financial industry. Rich will aid in the planned rapid corporate growth with Adoodle focusing on the new olfaction and behavioral modification industry,

Dr. V. Ruth Pinney is the Chief Scientist for Adoodle, Inc. She has over 30 years of experience in immunology, physiology, toxicology and indoor air quality research and development for Scripps Institute, University of California San Diego, Veteran’s Medical Center in San Diego, and the Office of Naval Research for the U.S. Navy. Dr. Pinney holds a Masters of Science in biology with emphasis in brain physiology and a Ph.D. in nutrition specializing in the area of chemical perception by smell and taste.

Victor Sonder brings more than 30 years of experience and widely recognized skills in marketing and strategic planning, copywriting, art direction, film and video direction/production to his role as member of the Adoodle Advisory Board, Victor began his career as a founding partner in SonderLevitt Advertising, a full-service agency at the forefront of the “creative revolution” on the East Coast. Over the years Victor has gained expertise in virtually every phase of the marketplace, from retail political, business-to-business and package goods to fast food, food service and high tech. His work in print, collateral design, radio, television and out-of-home advertising has been recognized nationally by the Clio Awards, New York Film Festival, Hollywood Radio & Television Awards, ADDY Awards and The One Club, among many others.

Roland “Rick” Perry is the Managing Director of Institutional Analyst Inc. (IA), an independent investment research and investor relations firm, as well as editor of eight industry specific investment reviews. He is the founder of the Chicago Stock, Bond & Futures Assoc., and of Blank Check Capital Corp., which recently participated in Wall Street’s first “Ultra Mini™” blank check offering, as President of Life Sciences Opportunities Inc., which successfully merged with Beverly Hills based “Dr Tattoff.”IA is a leading publisher of news, perspective and market intelligence reports on the equity markets. Working with publicly traded corporations; the firm works with small-cap companies that have products or services that can be defined as "best of breed."

William Lerner, Esq. has been engaged in the private practice of corporate and securities law in New York since 1961 and in Pennsylvania since 1990. He has served as chairman of the corporate governance and nominating committee of MTM Technologies since November 2003. Bill is also a director of Rent-way, Inc., New York Stock Exchange listed company engaged in the rental-purchase industry; and Cortland Trust, Inc., a money market mutual fund distributed primarily through securities brokerage firms and commercial banks. Along with the other members of the Advisory Board Bill will help the company in providing recommendations relating to the company’s business plans and transactions.

NOXO Behavioral Modification Products

NOXO Odor Inhibitor
New NOXO Odor Inhibitor balm, secret proprietary product formula of 14 special ingredients that blocks nauseating and offensive odors when applied topically, under the nostrils
NOXO Smoking Control
New NOXO Smoking Control balm, when applied topically, under the nostrils reduces an abstaining tobacco user's urge to smoke. The aroma of NOXO molecules transports their "messages" directly to the brain's limbic system, which controls tobacco cravings.

NOXO Autism Aid
New NOXO Autism Aid balm, when applied topically, under the nostrils helps settle brain waves and behavioral patterns back to normal by sending scent molecules into an autistic child’s system. NOXO Autism Aid has the ability to detoxify and oxygenate the body, something that research has found to help these special children by making them calmer, happier, relaxed, quieter with a feeling of well being.

NOXO Memory Boost
New NOXO Memory Boost balm, when applied topically, under the nostrils helps send an intense trigger for distinct and correlated past memories by delivering scent molecules into the brain's olfactory nerves. NOXO Memory Boost balm utilizes the new science of aromachology to detoxify and oxygenate the body. Research has been found that this process can help stimulate the olfactory receptors and therefore enhance one’s ability to perceive and improve memory recall.

NOXO Sweets Control
New NOXO Sweets Control balm, when applied topically, under the nostrils, desensitizes one’s desire to consume sweet foods. The craving to eat becomes diminished, triggering a positive, mood-enhancing benefit in the brain, which actually suppresses the desire to eat. Independent trials indicated that by using NOXO Sweets Control, individuals lost weight and stopped wanting sweet foods - particularly chocolate - within three weeks.

Tests showed that when the olfactory senses were saturated with NOXO Sweets Control, individuals no longer craved sweet foods. Once the appetite for sweet foods is diminished, the brain registers a decrease in the desire for very sweet tastes and dieting becomes easy. Test individuals did cut their consumption of sweet foods and did not increase their intake of fatty foods to compensate.

NOXO Anxiety Relief
New NOXO Anxiety Relief balm reduces anxiety associated with panic attacks, shortness of breath, dizziness, hot flashes and/or chills. NOXO Anxiety Relief balm reduces the startle reaction; also called the startle response, startle reflex or alarm reaction, which is the response of mind and body to a sudden unexpected stimulus, such as a flash of light, or a loud noise. NOXO Anxiety Relief also has calming effects due to the essential properties of its ingredients. In addition NOXO Anxiety Relief reduces stress and anxiety in cancer patients undergoing Magnetic Resonance Imaging by a massive 63 percent.

NOXO Mood Lifter
New NOXO Mood Lifter makes you feel your best in a Calm-Energy State. A mood is a relatively long lasting emotional state and is a product of two dimensions: energy and tension. A person can be energetic or tired while also being tense or calm. People feel best when they are in a calm-energy mood and the components of NOXO Mood Lifter balm enables the body to feel this fundamental mood connection. Where there is a food-mood connection, NOXO Mood Lifter balm decreases the desire for food and enables the calm-energy state to exist.

NOXO Appetite Control
New NOXO Appetite Control Improves Weight Loss And Weight Maintenance. Smelling food can trigger instinctive or mindless behavior and we therefore put food in our mouth. An emotional state could also trigger a desire for food. NOXO Appetite Control replaces these triggers and gives us control while replacing the need to eat the donut with the pleasure of feeling comfortable, at home, and secure at work. NOXO Appetite Control balm helps control appetite and all those irrational responses we have to food. NOXO Appetite Control balm used consciously gives us control of cravings where our own will power might fail

NOXO Nausea Relief
New NOXO Nausea Relief Is Effective In Reducing Nausea, Vomiting, Headache and Migraine. Both physiological and psychological problems can cause nausea. Not only are disgusting smells, bad digestion, tonsillitis, flu, migraine, hangover or food poisoning a reason for nausea, but allergies, motion sickness and early pregnancy can also be a factor. NOXO Nausea Relief balm may also be used as a headache or migraine remedy. That means you get natural headache relief just as potent as popping a couple of 500-milligram Tylenols, but without any long-term side effects or buildup of tolerance levels. And Tylenol doesn’t ease tension and relax your muscles like NOXO Nausea Relief balm can.

NOXO Stress Relief
New NOXO Stress Relief Is Effective In Relaxing Brain Waves And Reducing Stress And Toxins Stress is the term used to describe any reaction to a physical, mental or emotional stimulus that upsets the body's natural balance. Stress causes the entire body to malfunction, creating imbalances in all the systems of the body, resulting in obesity, exhaustion, digestive disorders, circulatory disorders and depression. Whether stress is related to work or family life, most of us experience too much stress in our daily life. Directions include keeping a stress diary for one week to identify what triggers stress in you. Taking NOXO at these trigger points can be a major step controlling and reducing harmful stress and the resulting toxins.

NOXO Menopausal Support
New NOXO Menopausal Support contains a blend of rose geranium and other oils to help lift your spirits and provide balance during your transition. This balm is to be applied behind your ears and rubbed into your palms so that you can inhale the fragrance from your hands by inhaling deeply three times.

NOXO Sleep Aid
The new NOXO Sleep Aid contains a blend of special essential oils to help lure your body into a relaxing sleep. Disturbed sleep is a perennial problem for those suffering from insomnia, restlessness, sleepwalking, nightmares, night terrors, nighttime aches and pains, snoring, or a partner or family member's loud snoring. NOXO Sleep Aid may bring relief and peaceful sleep to insomniacs.

NOXO balms, when applied topically, under the nostrils help deliver scent molecules into the nose to the olfactory bulb, where the chemical and neurotransmitter messengers are dispensed into the limbic system of the brain. From there, they are forwarded to areas of the central nervous system that mediate emotional, hormonal, metabolic, and other physiological responses throughout the body.

NOXO balms are proprietary product formulations of 16 or more unique and natural essential oils, which are coconut oil-based, are absorbed into the skin and are not visible after application. Based on olfactory perception altering technology, the NOXO line of products is focused on modifying behavior, via the olfactory senses and the limbic system.

Companies that are interested in becoming dealers can request an application at support (at) noxoinfo (dot) com

NOXO product information can also be found at: or by calling:
1- 484-278-1626; email: support (at) noxoinfo (dot) com

About Adoodle:
Adoodle’s NOXO division is focused on marketing a variety of products that can modify behavior, via olfactory senses, such as smoking cessation, autism, or weight control, as examples. NOXO products have the ability to alter the brains perception. The uniquely formulated NOXO product line is based on advanced olfactory perception altering technology and is proprietary to Adoodle, Inc,

NOXO product information can also be found at: or by calling:
1- 484-278-1626; email: support (at) noxoinfo (dot) com

Media Relations:
Tel: 951-657-8840
email: adde (at) wsmg (dot) biz

Safe Harbor for Public Companies

Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders. Adoodle, "The Company" currently does not file periodic filings with the Securities and Exchange Commission but will publish financials on the Adoodle website as they become available.

Richard Stevenson
Adoodle, Inc
333 E. Lancaster Ave.
Suite 317
Wynnewood, PA 19096

Phone: 484-278-1626


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... The American Association of ... local poison centers through donations on Tuesday, Dec. 1, 2015. Since 2012, the ... that inspires people to collaborate in improving their local communities and help give ...
(Date:11/24/2015)... ... November 24, 2015 , ... Aided by seed funding from the Ron ... designed to yield insights into how to detect and treat pancreatic cancer (PC). ... from small, non-coding RNA molecules (ncRNA), genetic material that is present in the blood ...
(Date:11/24/2015)... ... , ... Dr. Rodney E. Willey , has answered a new calling – to relieve ... provides treatment for snoring and sleep apnea through oral appliance therapy. He ... Disorders in the US, one of four in the Illinois area. , Dr. Willey’s ...
(Date:11/24/2015)... ... November 24, 2015 , ... Autism Speaks, the world’s leading ... driven by social media and the generosity of people around the world. On December ... media networks to give – and share the personal stories behind those gifts. ...
(Date:11/24/2015)... ... November 24, 2015 , ... Robert Yeager ... Report . Throughout the past year there have been multiple breakthroughs and challenges as ... this transition, PharmMD has enabled their customers and partners to stay ahead of the ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... LONDON , November 24, 2015 ... PCSK9 Inhibitors, CETP Inhibitors, MTTP Inhibitors, ApoB Inhibitors and ... areas are going to grow at the fastest rates? ... to 2025, assessing data, trends, opportunities and prospects there. ... graphs. Discover the most lucrative areas in the industry ...
(Date:11/24/2015)...  Enova Illumination is pleased to announce a new ... to combine their world class camera and ... of medical visualization: Enova is the first manufacturer of ... and Novocam is the manufacturer of HD ... most powerful battery-operated LED headlight with high-quality point-of-view video ...
(Date:11/24/2015)... Calif. , Nov. 24, 2015 Abaxis, ... manufacturing point-of-care instruments and consumables for the medical, research, ... Taylor , Chief Financial Officer, will present at the ... Tuesday, December 1, 2015 at 11:30 a.m. ET. The ... Palace in New York City . ...
Breaking Medicine Technology: